Skip to main content
. 2020 Jun 8;123(5):785–792. doi: 10.1038/s41416-020-0925-4

Fig. 1. Validation of the oestrogen receptor pathway test in normal endometrium from the endometrial tissue Affymetrix dataset.

Fig. 1

a Differences in ER pathway activity scores at the proliferative, early secretory and mid-secretory phase of the menstrual cycle, as measured in datasets GSE29981, GSE51981 and GSE6364. b Differences in ER pathway activity scores in postmenopausal women with inactive endometrium and endometrium treated with oestradiol, medroxyprogesterone acetate (MPA) or tibolone. Data are from dataset GSE12446. **P ≤ 0.01; ***P ≤ 0.001.